VULVAR SQUAMOUS CELL CARCINOMA
Clinical trials for VULVAR SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new VULVAR SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for VULVAR SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for Hard-to-Treat vulvar cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (cisplatin) and radiation can shrink or control advanced vulvar cancer that cannot be removed by surgery. About 24 participants will receive this combination therapy. The goal is to see …
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
Virus-Immunotherapy combo targets tough skin cancers
Disease control OngoingThis study tests a two-step treatment for people with rare skin cancers or certain lymphomas that haven't improved with standard care. First, patients receive a virus-based drug (talimogene laherparepvec) injected into tumors to help the immune system recognize and attack cancer …
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:47 UTC